A brain mass in a patient with Behcet’s disease: a case report
© AlFedaghi et al. 2015
Received: 24 April 2015
Accepted: 25 August 2015
Published: 30 September 2015
This case report describes an uncommon presentation of Behcet’s disease which manifested as neuro-Behcet’s disease. Although it is not the first reported case in the medical literature, it is a possible differential in a patient presenting with a brain tumor. Since the diagnosis of neuro-Behcet’s disease depends largely on the clinical picture and medical history, it should be considered prior to opting for invasive diagnostic methods.
Our patient is a 36-year-old white man from Kuwait. He presented with acute onset of headache, vomiting, and right-sided weakness. Magnetic resonance imaging of his brain showed a mass in the brain stem. He then revealed that he had a history of recurrent painful oral and genital ulcers for the past 10 years, which suggested a diagnosis of Behcet’s disease. A brain biopsy was recommended by a neurosurgeon at the time, but the patient refused the procedure. After initiating steroid therapy, the mass began to regress and, eventually, was undetectable on subsequent imaging of his brain.
This case of neuro-Behcet’s disease reflects the need to consider this diagnosis in a patient of less than 40 years of age presenting with a suspected brain tumor. This may delay the need for invasive diagnostic methods, especially if such methods are not desired by the patient. In the management of suspected neuro-Behcet’s disease, initiating steroid therapy and measuring the response is a reasonable option before seeking a definitive diagnosis via brain biopsy. If the response to steroids is minimal then a brain biopsy should be performed.
Behcet’s disease is an idiopathic chronic relapsing vasculitis characterized by recurrent oral aphthous ulcers, genital ulcers and uveitis. It is thought to be an autoimmune disease that can involve any organ system including the skin, lungs, joints, brain, cardiovascular system, and even the gastrointestinal and urinary tract. This disease usually manifests at an average age of 25 to 35 years, and the incidence of this disease is highest among people of Middle Eastern and Japanese descent . Neurological manifestations tend to affect 10 to 30% of patients and usually occur late in the disease . These include cerebral thrombosis in the arterial or venous systems, meningoencephalitis, demyelination, memory loss or behavioral changes and many others. It is uncommon for a patient with Behcet’s disease to present with an inflammatory pseudo-tumor in the brain . This case report discusses an unusual case of neuro-Behcet’s disease describing its clinical features, diagnostic modalities used and management. A similar case has been discussed in the literature with similar findings on magnetic resonance imaging (MRI) of the brain, but with a different clinical presentation .
A 36-year-old white Kuwaiti man presented with a 2-day history of headache and vomiting. The headache was localized to his left temporal area, continuous and pressing in nature. It was exacerbated by movement of his head, and associated with two episodes of vomiting. On physical examination, he was vitally stable; a neurological examination showed mild right-sided arm and leg weakness (4/5) with mild right-upper facial nerve palsy. Sensory and fundus examinations were normal, and examination of the other systems was unremarkable.
Neuro-Behcet’s disease is not uncommon but usually occurs late in the disease. It can affect both the central and peripheral nervous systems and the clinical manifestations of the disease depend on which part of the brain is affected. If the disease involves the central nervous system, it can result in lesions in the brain hemisphere manifesting as aphasia, limb weakness or numbness or it can affect the brainstem causing problems with vision, hearing or, sometimes, change in mental status and respiratory arrest. The spinal cord can be affected resulting in bilateral limb paresis with problems with urination and defecation. Neuro-Behcet’s disease can also affect the brain in other ways such as in dural sinus thrombosis resulting in intracranial hypertension, headache, papilledema, seizures and nerve palsy. Arterial occlusion or aneurismal dilatation are less common than venous involvement but have a worse prognosis and can present with signs and symptoms of cerebrovascular accident . In our case, the patient presented with acute onset of headache, vomiting and mild weakness suggestive of increased intracranial pressure despite normal imaging of the venous and arterial system of his brain. Imaging revealed a mass in his brain stem, which was thought to be a brain tumor.
According to Chae et al., MRI findings of neuro-Behcet’s disease typically present as round or linear hypointensities in T1-weighted images or as high signal intensities in T2-weighted images affecting the cerebral peduncles, pons, thalamus and basal ganglia . Rarely, it can be viewed as an atypical space-occupying lesion mimicking lymphoma, primary or secondary brain tumor or even an abscess. Some authors do recommend stereotactic biopsy to rule out malignancy, but it is unnecessary for the diagnosis of neuro-Behcet’s disease. A biopsy would show perivascular infiltration of leukocytes and microglia, oligodendroglial degeneration, diapedetic bleeding, and areas of necrosis . In our patient, imaging of his brain showed atypical features of neuro-Behcet’s disease and a biopsy was recommended by neurosurgery; however, the patient refused and decided on medical treatment before employing invasive measures. Even though brain lymphoma was a possibility, the classic history of recurrent oral and genital ulcers, the clinical context, acute symptoms and the significant response to steroids, made the possibility of lymphoma less likely especially as our patient is HIV negative and because of his blood culture results. There are multiple case reports that presented similarly to this case and they were proven by biopsy to be neuro-Behcet’s disease, so in the context of Behcet’s disease the clinical picture is more important that a brain biopsy .
The gold standard for treatment of neuro-Behcet’s disease is methylprednisolone administered as 1 gm per day for 1 week, followed by prednisone 0.5 to 1mg/kg/day with gradual tapering over the next 2 to 3 months. This treatment modality is considered the standard by many physicians. Other treatment modalities include azathioprine, methotrexate, cyclophosphamide, and anti-tumor necrosis factor (TNF) drugs as well as interferon-α, chlorambucil, and mycophenolate mofetil. These treatment modalities have not been studied well in the treatment of neuro-Behcet’s disease . Even though neuro-Behcet’s disease is known to be associated with poor prognosis, the patient in the case described improved dramatically with pulse steroids and is currently on a small dose of prednisone with regular follow-up. We suggest that in a background of history indicative of Behcet’s disease, in a patient refusing a brain biopsy, delaying a biopsy and treating the patient with steroids with good follow-up as well as measuring the response to treatment is a plausible option. If the response is suboptimal then a biopsy is advised.
Behcet’s disease is a form of vasculitis that may affect any organ system including the central nervous system. Neurological manifestations of this disease usually occur late in the disease course and are severe. It can affect the parenchyma, venous or arterial system of the brain resulting in a variety of symptoms and signs depending on the affected site. MRI is the modality of choice and typically shows lesions in the brain stem or, atypically, a space-occupying lesion in the brain. Our case presented with an acute onset of headache, vomiting and limb weakness with an atypical brain mass on imaging, which responded significantly to steroid therapy. This suggests the importance of thorough history taking in any patient with suspected brain tumor. In a background of history indicative of Behcet’s disease, in a patient refusing a brain biopsy, delaying a brain biopsy and treating the patient with steroids with good follow-up as well as measuring the response to treatment is a plausible option. If the response is suboptimal then a biopsy is advised.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
No other person other than the mentioned authors has contributing in the making of this case report. There has been no funding involving the writing of the case report for any of the authors.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Alnaimat F. Behcet disease. http://emedicine.medscape.com/article/329099-overview (16 December 2014). Accessed 17 April 2015.
- Lee S, Choi SJ, Kim SD, Lim DJ. Rapid atypical progression of Neuro-Behçet’s disease involving whole brainstem and bilateral thalami. J Korean Neurosci. 2011;50(1):68–71.View ArticleGoogle Scholar
- Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behçet disease. A review. Neurologist. 2005;11(2):80–9.View ArticlePubMedGoogle Scholar
- Chae E, Do KH, Seo JB, Park SH, Kang JW, Jang YM, et al. Radiologic and clinical findings of Behçet disease: comprehensive review of multisystemic involvement. Radiographics. 2008;28(5):e31.View ArticlePubMedGoogle Scholar